PRESS RELEASE published on 10/31/2025 at 18:52, 5 months 5 days ago Informations privilégiées / Autres communiqués Nomination de Yves Decadt en tant que membre du Conseil d'administration de Poxel renforce la structuration stratégique et commerciale de la société biopharmaceutique au stade clinique. Double expertise scientifique et stratégique apportée par Yves Decadt Conseil D'administration Biopharmaceutique Traitement Poxel Yves Decadt
BRIEF published on 10/16/2025 at 17:56, 5 months 20 days ago Poxel : Résultats financiers 2024 et procédure de redressement judiciaire Résultats Financiers Trésorerie Redressement Judiciaire TWYMEEG® Poxel
BRIEF published on 10/16/2025 at 17:56, 5 months 20 days ago Poxel: 2024 financial results and receivership proceedings Financial Results Treasury TWYMEEG® Poxel Judicial Recovery
PRESS RELEASE published on 10/16/2025 at 17:51, 5 months 20 days ago Informations privilégiées / Communiqué sur comptes, résultats Poxel annonce ses résultats financiers 2024 avec des redevances positives pour TWYMEEG® et une procédure de redressement judiciaire en cours, plans de continuité et perspectives de ventes au Japon Résultats Financiers Redressement Judiciaire Poxel Redevances Ventes Japon
PRESS RELEASE published on 10/16/2025 at 17:51, 5 months 20 days ago Inside Information / News release on accounts, results Poxel reports financial results for full year 2024, including positive net royalties and governance changes. Updates on operational and financial status provided. Commercial momentum for TWYMEEG® in Japan. Cash position and financing details shared Financial Results Cash Position Governance Changes TWYMEEG® Poxel
BRIEF published on 08/08/2025 at 17:50, 7 months 28 days ago POXEL Entame une Procédure de Redressement Judiciaire Maladies Métaboliques Redressement Judiciaire Cotation Euronext Période D'observation Stéatohépatite
BRIEF published on 08/08/2025 at 17:50, 7 months 28 days ago POXEL Begins Judicial Reorganization Proceedings Metabolic Diseases Euronext Listing Judicial Recovery Steatohepatitis Observation Period
PRESS RELEASE published on 08/08/2025 at 17:45, 7 months 28 days ago Informations privilégiées / Autres communiqués POXEL annonce l'ouverture d'une procédure de redressement judiciaire avec reprise de cotation de l'action le 11 août 2025. La société biopharmaceutique explore ses options pour poursuivre ses activités Biopharmaceutique Cotation Redressement Judiciaire Procédure Poxel
BRIEF published on 07/29/2025 at 20:21, 8 months 7 days ago Poxel Initiates Reorganization Amid Financial Struggles Creditors Reorganization Insolvency Corporate Changes Poxel
BRIEF published on 07/29/2025 at 20:21, 8 months 7 days ago Poxel entame une réorganisation en raison de difficultés financières Créanciers Reorganisation Insolvabilité Poxel Changements D'entreprise
Published on 04/02/2026 at 22:00, 3 days 6 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 3 days 10 hours ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 3 days 13 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 days 14 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 days 14 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 1 day 18 hours ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 2 days 2 hours ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 2 days 10 hours ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 2 days 10 hours ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 2 days 10 hours ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 2 days 9 hours ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 2 days 9 hours ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 2 days 10 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 10 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 10 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026